Form 4 for TEVA TEVA PHARMACEUTICAL INDUSTRIES LTD
Accepted 2025-06-05 00:00:00 ET · period of report 2025-06-03 · accession 0000950170-25-082498 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-06-05 | 2025-06-03 | TEVA | Shields Matthew | EVP, Gbl Ops | S - Sale+OE | $17.02 | -6,206 | 9,989 | -38% | -$105.6K |
| D | 2025-06-05 | 2025-06-03 | TEVA | Shields Matthew | EVP, Gbl Ops | M - OptEx | — | +16.2K | 16.2K | New | — |
| D | 2025-06-05 | 2025-06-03 | TEVA | Shields Matthew | EVP, Gbl Ops | M - OptEx | $0.00 | -16.2K | 48.6K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-06-03 | S | D | 6,206 | $17.02 | 9,989 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F3) Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II. |
| 2 | Common | Ordinary Shares | 2025-06-03 | M | A | 16,195 | — | 16,195 | D | — | — | (F1) The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. |
| 3 | Derivative | Restricted Share Units | 2025-06-03 | M | D | 16,195 | $0.00 | 48,587 | D | — · — to — | 16,195 Ordinary Shares | (F2) Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share. (F4) Restricted share units were granted on June 3, 2024 with 16,195 vested on June 3, 2025, 16,195 vesting on each of June 3, 2026 and June 3, 2027, and 16,197 vesting on June 3, 2028. |